Overview
Nanox.AI, developed by Nanox, offers FDA-cleared AI solutions designed to assist in the early detection and management of chronic diseases. These solutions leverage advanced algorithms to analyze medical imaging data, highlighting potential indicators of asymptomatic conditions. The suite includes solutions for cardiac disease (HealthCCSng), liver disease (HealthFLD), and bone health (HealthOST), among others. By identifying patients who may benefit from early intervention, Nanox.AI aims to improve patient outcomes and reduce the overall burden of chronic diseases. The platform is targeted towards radiologists, healthcare providers, and medical facilities seeking to enhance diagnostic accuracy and efficiency through the integration of artificial intelligence.
Common tasks